75 results
Page 3 of 4
10-K
j8ygmlb1eixa55
1 Mar 21
Annual report
12:00am
10-K
EX-10.32
qwt0qzx42fw8hdu
1 Mar 21
Annual report
12:00am
10-K
EX-10.22
ggvlj1 msl
1 Mar 21
Annual report
12:00am
10-K
EX-10.21
s6wzl
1 Mar 21
Annual report
12:00am
10-K
EX-10.33
g6odr ghcejx8m1g1
1 Mar 21
Annual report
12:00am
8-K
EX-99.1
fbzo2mwe zch
11 Jan 21
Zai Lab Secures Exclusive Right to Develop and Commercialize TPX-0022, Turning
6:52am
6-K
EX-99.1
tfh9ufa9uu6vlthz0
28 Sep 20
Zai Lab Announces Closing of Hong Kong Secondary Listing
7:52am
6-K
EX-99.1
hgp67 cuqy
22 Sep 20
Zai Lab Announces Pricing of Hong Kong Secondary Listing
8:08am
6-K
EX-1.1
38e11v78hv mwnmud4cg
21 Sep 20
Current report (foreign)
4:15pm
6-K
EX-99.1
ibvw2d6o5y
16 Sep 20
Zai Lab Launches Hong Kong Secondary Listing
7:18am
6-K
EX-99.1
7kx3skih6wp778y339g1
11 Sep 20
Zai Lab Limited Supplemental and Updated Disclosures
8:09am
6-K
EX-99.1
rhd9rp21jrx
10 Sep 20
Zai Lab Announces NMPA Approval of ZEJULA® (Niraparib) for First-Line Maintenance Treatment of Ovarian Cancer in China
7:35am
6-K
EX-99.1
d84tkv pm9ndtgadz
27 Jan 20
Zai Lab Announces Closing of Public Offering of American Depositary Shares and Full Exercise of Greenshoe Option
4:41pm
424B2
qgpxbfc
24 Jan 20
Prospectus for primary offering
7:24am
6-K
EX-99.1
optid2m2z6esrgqk
23 Jan 20
Zai Lab Announces Pricing of Public Offering of American Depositary Shares
6:08am
6-K
EX-1.1
ouyg9
22 Jan 20
Current report (foreign)
11:58am
424B5
vz1ovrkncrwlcywvmmco
21 Jan 20
Prospectus supplement for primary offering
5:31pm